Effect of retinoic acid on leptin, glycerol, and glucose levels in mature rat adipocytes in vitro

Journal of Medicinal Food

Volumn 7, Issue 3, 2004, Pages 320-326

  Hong, Seong Eui ^a   Ahn, In Sook ^a   Jung, Hun Soon ^a   Rayner, D Vernon ^b   Do, Myoung Sool ^a  

^a Handong University   (South Korea)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Adipocytes; Leptin; Retinoic acid; Retinoid X receptor peroxisome proliferator activated receptor heterodimer; Type II diabetes

Indexed keywords

ALITRETINOIN; ANTIDIABETIC AGENT; GLUCOSE; GLYCEROL; LEPTIN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOIC ACID; RETINOID X RECEPTOR; ROSIGLITAZONE;

ADIPOCYTE; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL LEVEL; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; GLUCOSE TRANSPORT; IN VITRO STUDY; INSULIN SENSITIVITY; LIPOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; PROTEIN SECRETION; RAT;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; GENE EXPRESSION REGULATION; GLYCEROL; ISOMERISM; LEPTIN; MALE; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RETINOID X RECEPTORS; THIAZOLIDINEDIONES; TRETINOIN;

ANIMALIA;

EID: 4644317876     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2004.7.320     Document Type: Article

References (54)

1. Wolf G: The discovery of the visual function of vitamin A. J Nutr 2001;131:1647-1650.
2. Underhill TM, Sampaio AV, Weston AD: Retinoid signaling and skeletal development. Novartis Found Symp 2001;232:171-185.
3. Zile MH: Function of vitamin A in vertebrate embryonic development. J Nutr 2001;131:705-708.
4. Simoni D, Tolomeo M: Retinoids, apoptosis and cancer. Curr Pharm Des 2001;7:1823-1837.
5. Black RE: Micronutrients in pregnancy. Br J Nutr 2001;85(Suppl): S193-S197.
6. Blumentrath J, Neye H, Verspohl EJ: Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells. Cell Biochem Funct 2001;19:159-169.
7. Codner E, Loviscach M, Ciaraldi TP, Rehman N, Carter L, Mudaliar S, Henry RR: Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals. Metabolism 2001;50:830-834.
8. Singh Ahuja H, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies PJ: Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol 2001; 59:765-773.
9. Emilsson V, O'Dowd J, Wang S, Liu YL, Sennitt M, Heyman R, Cawthorne MA: The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat. Metabolism 2000;49:1610-1615.
10. Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE, Paterniti JR: A selective peroxisome proliferator-activated receptor-gamma (PPAR gamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol 2000;14:1425-1433.
11. Liu YL, Sennitt MV, Hislop DC, Crombie DL, Heyman RA, Cawthorne MA: Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats. Int J Obes Relat Metab Disord 2000;24:997-1004.
12. Villarroya F, Giralt M, Iglesias R: Retinoids and adipose tissues: metabolism, cell differentiation and gene expression. Int J Obes Relat Metab Disord 1999;23:1-6.
13. Rastinejad F: Retinoid X receptor and its partners in the nuclear receptor family. Curr Opin Struct Biol 2001;11:33-38.
14. Johnson A, Chandraratna RA: Novel retinoids with receptor selectivity and functional selectivity. Br J Dennatol 1999;140:12-17.
15. Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG: RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 1992;11:1409-1418.
16. Marks MS, Hallenbeck PL, Nagata T, Segars JH, Appella E, Nikodem VM, Ozato K: H-2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive gene. EMBO J 1992;11:1419-1435.
17. Zechel C, Shen X, Chen J, Chen Z, Chambon P, Gronemeyer H: The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full length receptors to direct repeats. EMBO J 1994;13:1425-1433.
18. Zhang XK, Hoffmann B, Tran PB, Graupner G, Pfahl M: Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992;355:441-446.
19. Kliewer SA, Umesono K, Mangelsdorf DJ, Evans RM: Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signaling. Nature 1992;355:446-449.
20. Qi C, Zhu Y, Reddy JK: Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell Biochem Biophys 2000;32:187-204.
21. Schoonjans K, Staels B, Auwerx J: The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996;26: 93-109.
22. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 1995;83:841-850.
23. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Jastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: the second decade. Cell 1995;83:835-839.
24. Bardot O, Aldridge TC, Latruffe N, Green S: PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene. Biochem Biophys Res Commun 1993;192:37-45.
25. Issemann I, Prince RA, Tugwood JD, Green S: The peroxisome proliferator-activated receptor: retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs. J Mol Endocrinol 1993;11:37-47.
26. Escher P, Wahli W: Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 2000;17:121-138.
27. Michalik L, Wahli W: Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions. Curr Opin Biotechnol 1999;10:564-570.
28. Zhou YT, Shimabukuro M, Wang MY, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH: Induction for leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci U S A 1997;95:8898-8903.
29. Issemann I, Staels B, Auwerx J: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-650.
30. Moller DE, Greene DA: Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes. Adv Protein Chem 2001;56:181-212.
31. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 2001;409:307-312.
32. Lehmann JM: An antidiabetic thiazolidinediones is a high affinity ligand for the nuclear peroxisome proliferator-activated receptorγ (PPARγ). J Biol Chem 1995;270:12953-12956.
33. Halimi S: Type 2 diabetes mellitus: which place for thiazolidinediones in the therapeutic strategy? Diabetes Metab 2001;27: 287-293.
34. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J: Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J Clin Invest 1996;98:1004-1009.
35. Kelly LJ, Vicario PP, Thompson GM, Candelore MR, Doebber TW, Ventre J, Wu MS, Meurer R, Forrest MJ, Conner MW, Cascieri MA, Moller DE: Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression. Endocrinology 1998;139:4920-4927.
36. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001;50:2094-2099.
37. Prolo P, Wong ML, Licinio J: Leptin. Int J Biochem Cell Biol 1998;30:1285-1290.
38. Castagna L, De Gregorio T, Allegra A, Buemi M, Corsonello A, Bonanzinga S, Catanoso M, Ceruso D, Corica F: Leptin: adipocyte hormone. Recenti Prog Med 1998;89:200-207.
39. Pellymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-543.
40. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
41. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
42. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, Mckee LJ, Bauer TL, Caro JF: Serum immunoreactive- leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
43. Sinha MK, Ohannesiasn JP, Heiman ML, Kriauciunas A, Stephens TW, Magosin S, Macro C, Caro JF: Nocturnal rise in leptin in lean, obese, and non-insulin dependent diabetes mellitus subjects. J Clin Invest 1995;97:1344-1347.
44. McGregor GP, Desega JF, Ehlenz K, Fischer A, Hesse F, Hegele A, Lammar C, Peiser C, Lang RE: Radioimmunological measurement of leptin in plasma of obese and diabetic subjects. Endocrinology 1996;137:1501-1504.
45. Saladin R, De Vos P, Guerre-Millo M, Leturque A, Girad J, Staels B, Auwerx J: Transient increase in obese gene expression after food intake or insulin administration. Nature 1995;377:527-529.
46. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: evidence for diet induced resistance to leptin action. Nat Med 1995;1: 1311-1314.
47. Mizuno TM, Bergen H, Funbashe T, Kleopoulos SP, Zhong Y, Bauman WA, Mobbs CV: Obese gene expression: reduction by fasting and stimulation by insulin and glucose in élan mice, and persistent elevation in acquired (diet-induced) and genetic (yellow agouti) obesity. Proc Natl Acad Sci U S A 1996;93:434-438.
48. Tartaglia LA, Dembbski M, Weng X, Deng N, Culpepper J, Devos R, Rchards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271.
49. Wang MY, Lee Y, Unger RH: Novel form of lipolysis induced by leptin. J Biol Chem 1999;274:17541-17544.
50. Unger RH, Zhou YT, Orci L: Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci U S A 1999;96:2327-2332.
51. Foley JE, Foley R, Gliemann J: Glucose-induced acceleration of deoxyglucose transport in rat. J Biol Chem 1980;255: 9674-9677.
52. Alvarez R, Anres J, Yubero P, Vinas O, Mampel T, Iglesias R, Giralt M, Villarroya F: A novel regulatory pathway of brown fat thermogenesis: retinoic acid is a transcriptional activator of the mitochondrial uncoupling protein gene. J Biol Chem 1995;270: 5666-5673.
53. Haq R, Chytil F: Expression of nuclear retinoic acid receptors in rat adipose tissue. Biochem Biophys Res Commun 1991;176: 1539-1544.
54. Kamei Y, Kawada T, Kazuki R, Sugimoto E: Retinoic acid receptor gamma 2 gene expression is up-regulated by retinoic acid in 3T3-L1 preadipocytes. J Biochem (Tokyo) 1993;293:807-812.